Author:
Rinchai Darawan,Kabeer Basirudeen,Toufiq Mohammed,Calderone Zohreh,Deola Sara,Brummaier Tobias,Garand Mathieu,Branco Ricardo,Baldwin Nicole,Alfaki Mohamed,Altman Matthew,Ballestrero Alberto,Bassetti Matteo,Zoppoli Gabriele,De Maria Andrea,Tang Benjamin,Bedognetti Davide,Chaussabel Damien
Abstract
SUMMARYCovid-19 morbidity and mortality are associated with a dysregulated immune response. Tools are needed to enhance existing immune profiling capabilities in affected patients. Here we aimed to develop an approach to support the design of focused blood transcriptome panels for profiling the immune response to SARS-CoV-2 infection. We designed a pool of candidates based on a pre-existing and well-characterized repertoire of blood transcriptional modules. Available Covid-19 blood transcriptome data was also used to guide this process. Further selection steps relied on expert curation. Additionally, we developed several custom web applications to support the evaluation of candidates. As a proof of principle, we designed three targeted blood transcript panels, each with a different translational connotation: therapeutic development relevance, SARS biology relevance and immunological relevance. Altogether the work presented here may contribute to the future expansion of immune profiling capabilities via targeted profiling of blood transcript abundance in Covid-19 patients.
Publisher
Cold Spring Harbor Laboratory
Reference68 articles.
1. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multicenter study in Wenzhou city, Zhejiang, China;J Infect,2020
2. Clinical Characteristics of Coronavirus Disease 2019 in China;N Engl J Med,2020
3. Long Q-X , Liu B-Z , Deng H-J , Wu G-C , Deng K , Chen Y-K , et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020 Apr 29;
4. Henderson LA , Canna SW , Schulert GS , Volpi S , Lee PY , Kernan KF , et al. On the Alert for Cytokine Storm: Immunopathology in COVID-19. Arthritis Rheumatol Hoboken NJ. 2020 Apr 15;
5. Assessment of immune status using blood transcriptomics and potential implications for global health